Summit Securities Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Hold
0
1238
2022
Q3
Hold
0
1028
2019
Q3
Sell
-7,659
Closed -$335K 277
2019
Q2
$335K Buy
+7,659
New +$335K 0.04% 91